
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
Check out this week’s headlines
Good afternoon dvm360 readers and happy Friday! Earlier this week, dvm360 announced that this will be our last year hosting our Fetch Coastal conference in Atlantic City, New Jersey. Instead of AC, Fetch Coastal will officially move into its new home of National Harbor, Maryland for 2025. You can learn more about the move
Check out what was popular this week on dvm360.com:





